MHRA Drug Safety Update May 2023
Links to the MHRA Drug Safety Update for May 2023 below.
- Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment
- Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions instead of saline solutions in arterial lines
- Febuxostat: updated advice for the treatment of patients with a history of major cardiovascular disease
- Letters and medicine recalls sent to healthcare professionals in April 2023
Published 02/06/2023. Medicines Update blogs are correct at the time of publication.
If you would like to subscribe to Medicines Update or provide feedback on the blogs, email medicines.update@ggc.scot.nhs.uk.
Follow Medicines Update on Twitter @NHSGGCMeds